IP Library › Granted Patent US 10,561,729
Granted Patent B2
US 10,561,729 · App. 16/323,747 · Granted Feb 18, 2020

Near-IR light-cleavable conjugates and conjugate precursors

Inventors: Martin John Schnermann (Rockville, MD); Roger Rauhauser Nani (Frederick, MD); Alexander Patrick Gorka (Frederick, MD)
Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
A61K41/0042A61K47/545A61K47/6829A61K47/6845A61K49/0032A61K49/0058A61P35/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,561,729
App. No.
16/323,747
Granted
Feb 18, 2020
Kind
B2
Abstract

Embodiments of near-infrared light-cleavable heptamethine cyanine-based conjugates, particularly targeting agent-drug conjugates, according to Formula I and conjugate precursors are disclosed. The disclosed targeting agent-drug conjugates are useful for targeted delivery and release of a drug. Methods of making and using the conjugates and precursors also are disclosed.

Claims (28)

1. A precursor compound having a structure according to Formula IV, or a salt thereof:

wherein m is 1, 2, 3, 4, or 5;

each n independently is 1, 2, or 3;

R 1 and R 4 independently are alkyl, haloalkyl, cycloalkyl, alkoxy, —ROH, —RC(O)OH, —C(O)—R, or —C(O)—O—R, wherein R is alkyl;

R 2 is C(R c ) 2 wherein each R c independently is H, halo, alkyl, or aryl, or (R 2 ) m collectively is phenyl;

X 1 is O, N, or CH 2 ;

G 1 is

G 2 is

R 6 and R 7 independently are alkyl sulfonate, H, alkyl, alkoxy, or substituted aminoalkyl;

R 8 -R 19 independently are H, alkyl, amino, alkoxy, or alkyl sulfonate;

each Y independently is C(R d ) 2 , S, O, Se, or N(R d ) wherein each R d independently is alkyl or H;

each ring A independently is a 6-membered fused aryl, aliphatic, heteroaliphatic, or heteroaryl ring;

R 28 is hydrogen or a protecting group; and

R 29 is —(CH 2 ) u —C≡CH where u is 1, 2, 3, 4, or 5.

2. The precursor compound of claim 1 , wherein the precursor compound is

wherein R 1 and R 4 are methyl, ethyl, n-propyl, i-propyl, t-butyl, or —(CH 2 ) 2 OH; and

R 6 and R 7 are —(CH 2 ) p SO 3 − or —(CH 2 ) p N(CH 3 ) 3 + , where p is 1, 2, 3, 4, or 5.

3. The precursor compound of claim 1 , wherein R 28 is hydrogen, tert-butyloxycarbonyl, or 9-fluorenylmethyloxycarbonyl.

4. The precursor compound of claim 1 , wherein R 28 is hydrogen.

5. The precursor compound of claim 1 , wherein R 6 and R 7 independently are alkyl sulfonate or substituted aminoalkyl.

6. The precursor compound of claim 1 , wherein R 6 and R 7 independently are —(CH 2 ) p SO 3 − or —(CH 2 ) p N(CH 3 ) 3 − , where p is 1, 2, 3, 4, or 5.

7. The precursor compound of claim 1 , wherein:

R 6 and R 7 are —(CH 2 ) 4 SO 3 − ; or

R 6 and R 7 are —(CH 2 ) 4 N(CH 3 ) 3 + .

8. The precursor compound of claim 1 , wherein R 8 -R 19 are H.

9. The precursor compound of claim 1 , wherein each Y independently is C(CH 3 ) 2 or S.

10. The precursor compound of claim 1 , wherein each Y is C(CH 3 ) 2 .

11. The precursor compound of claim 1 , wherein each ring A is a fused phenyl ring substituted with —SO 3 − .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2019
From: SCHNERMANN, MARTIN JOHN; NANI, ROGER RAUHAUSER; GORKA, ALEXANDER PATRICK; KOBAYASHI, HISATAKA
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 048262/0964 →
Continuity (2)
Provisional Application 62373666 · Aug 11, 2016
Related Publication 20190167793A1 · Jun 6, 2019